- The trend backdrop is active with a 4-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
JUBLINGREA
NSI
Week ended 31 Jul 2026
Weekly Investor Report
Jubilant Ingrevia Limited · Basic Materials · Specialty Chemicals
Latest close
735.0 INR
1.3%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 12.2% above the Trend Line and sits at 77.5% of its 52-week range. The latest completed week returned 1.3%, after a 8.6% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 54/100. Near-term considerations: volume confirmation is below normal.
Setup score
61
out of 100
Latest Close
735.0 INR
31 Jul 2026
1W Return
1.3%
latest completed week
4W Return
8.6%
short-term follow-through
12W Return
-1.0%
quarterly tape
Trend Breadth
19.2%
10 of 52 weeks active
Volume Ratio
0.7x
vs 13-week average
- No major top-level risk cluster is currently dominant.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
1.3%
Latest completed week; four-week move 8.6%.
Indicator stack
24/100
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
54/100
32 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 12.2% above the Trend Line and sits at 77.5% of its 52-week range. The latest completed week returned 1.3%, after a 8.6% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.5312-week average 0.48
12-week confirmation
Trend active4/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership7/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.53Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 8.6% over four weeks, -1.0% over 12 weeks, and -2.2% over one year. The current trend has remained active for 4 consecutive weeks.
Performance by holding period
Active trend streak4 weeks
Active weeks in one year10
Trend breadth19.2%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.56Latest activity-pressure read.
Pressure change832.2%Four-week change in activity pressure.
Leadership11.21Latest relative-leadership reading.
RS change364.3%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.
Factor week 26 Jul 2026
Financial statements through 31 Mar 2026
Field coverage 94%
Model confidence 94%
Relative factor standing
Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.
Overall factor strength35/100Blend of value, momentum, and quality. Underlying universe rank 66; rank 1 is best.
Value35/100Relative valuation strength. Underlying universe rank 66; rank 1 is best.
Quality73/100Profitability and accounting quality. Underlying universe rank 28; rank 1 is best.
Momentum34/100Medium-term price momentum. Underlying universe rank 67; rank 1 is best.
Growth28/100Revenue and earnings growth. Underlying universe rank 73; rank 1 is best.
Quality and valuation are separate questions
A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.
Value-quality framework33/100Value and quality alignment from the Sharemaestro SVQF framework.
Valuation
How much investors are paying for earnings, sales, and cash flow.
- P/E
- 36.4x Price divided by trailing earnings.
- Price / sales
- 2.5x Market value relative to trailing revenue.
- EV / EBITDA
- 18.3x Enterprise value relative to operating cash earnings.
- Free-cash-flow yield
- 1.9% Free cash flow as a share of enterprise value.
Business quality
Margins and the return generated on invested capital.
- Gross margin
- 48.7% Gross profit retained from each unit of revenue.
- Operating margin
- 9.8% Operating profit retained from revenue.
- Free-cash-flow margin
- 5.0% Free cash flow generated from revenue.
- Return on invested capital
- 8.9% Operating return generated on invested capital.
Growth and financial strength
Recent business growth and accounting strength.
- Revenue growth
- 5.4% Latest one-year revenue growth.
- EPS growth
- 10.9% Latest one-year earnings-per-share growth.
- Free-cash-flow growth
- 58.0% Latest one-year free-cash-flow growth.
- Piotroski F-score
- 6/9 Nine-point accounting-strength checklist.
Shareholder return and balance sheet
Cash returned to owners and financial leverage.
- Dividend yield
- 0.7% Cash dividends relative to market value.
- Buyback yield
- 0.3% Net share repurchases relative to market value.
- Shareholder yield
- 1.0% Dividend yield plus net buyback yield.
- Net debt / EBITDA
- 0.9x Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment54/100
Weighted news tone is neutral across 32 relevant articles.
9 positive · 22 neutral · 1 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-7.2%Distance below the 52-week high.
13-week volatility4.8%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
6 Mar
3 Apr
1 May
29 May
26 Jun
31 Jul
Weeks higher12 of 2614 weeks finished lower.
Best week+11.9%Week of 10 Apr.
Worst week-11.2%Week of 29 May.
Latest week+1.3%Week of 31 Jul.
Shape of recent returns
Strong gains7
Modest gains5
Flat weeks0
Modest losses11
Sharp losses3
Recent vol4.8%13-week weekly-return volatility.
Base vol4.6%52-week weekly-return volatility.
Up/down split25/27Count of positive and negative weeks in the 52-week window.
Average skew3.9% / -3.5%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIN Basic Materials
4-week rank10 / 100
Group average-0.3%
Trend breadth49.0%
Trend49.0%active weekly trend signals
MD53.0%positive activity pressure
RS57.0%positive relative leadership
Four-week leaders
IndustryIN Specialty Chemicals
4-week rank26 / 100
Group average2.6%
Trend breadth70.0%
Trend70.0%active weekly trend signals
MD80.0%positive activity pressure
RS68.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape59/100
Trend, activity pressure, participation, and risk combine to a 59/100 tape read.
Indicator analysis57/100Latest 12-week confirmation: trend 4/12, activity pressure 11/12, relative leadership 7/12.
Activity pressure 0.53; No reversal markers Factors44/100O'Shaughnessy factor stack blends value, quality, momentum, and confidence.
Buyback Yield rank 3; Small Cap Core rank 58 SVQF33/100Value and quality alignment from the Sharemaestro SVQF framework.
Composite rank 1070.5 of 1590 Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment54/100Weighted news tone is neutral across 32 relevant articles.
The Jubilant Ingrevia Limited (NSE:JUBLINGREA) First-Quarter Results Are Out And Analysts Have Published New Forecasts Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 31 Jul 2026 | 735.0 INR | 1.3% | 654.9 INR | 621.7 INR | 0.56 | 11.21 | 1.2M | On |
| 24 Jul 2026 | 725.5 INR | -1.5% | 654.5 INR | 619.7 INR | 0.63 | 12.59 | 7.2M | On |
| 17 Jul 2026 | 736.6 INR | 2.3% | 653.9 INR | 617.7 INR | 0.40 | 11.58 | 2.1M | On |
| 10 Jul 2026 | 719.9 INR | 6.4% | 653.0 INR | 615.5 INR | 0.27 | 9.41 | 2.9M | On |
| 3 Jul 2026 | 676.7 INR | 9.2% | 652.1 INR | 613.5 INR | 0.06 | 2.41 | 1.9M | Off |
| 26 Jun 2026 | 619.6 INR | -2.5% | 652.3 INR | 611.7 INR | -0.04 | -5.58 | 0 | Off |
| 19 Jun 2026 | 635.5 INR | 1.9% | 655.2 INR | 610.4 INR | 0.19 | -3.20 | 371.2K | Off |
| 12 Jun 2026 | 623.4 INR | -0.5% | 657.9 INR | 609.0 INR | 0.39 | -3.57 | 182.8K | Off |
| 5 Jun 2026 | 626.2 INR | -3.1% | 659.8 INR | 607.8 INR | 0.64 | -2.44 | 113.8K | Off |
| 29 May 2026 | 646.2 INR | -11.2% | 660.7 INR | 606.5 INR | 0.89 | -0.19 | 2.4M | Off |
| 22 May 2026 | 727.8 INR | -0.6% | 662.1 INR | 604.9 INR | 0.98 | 11.53 | 994.1K | Off |
| 15 May 2026 | 731.8 INR | -1.5% | 660.3 INR | 602.7 INR | 1.10 | 12.77 | 991.2K | Off |
| 8 May 2026 | 742.6 INR | 4.0% | 659.1 INR | 600.4 INR | 0.95 | 12.19 | 937.7K | Off |
| 1 May 2026 | 713.8 INR | -3.4% | 656.0 INR | 598.3 INR | 0.68 | 8.79 | 793.2K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.